Incidence of endocrine toxicities in patients with solid tumor malignancies receiving curative-intent immune checkpoint inhibitor (ICI) therapy: A single institution experience.
Saved in:
| Title: | Incidence of endocrine toxicities in patients with solid tumor malignancies receiving curative-intent immune checkpoint inhibitor (ICI) therapy: A single institution experience. |
|---|---|
| Authors: | Kurz H; Department of Pharmacy, Atrium Health Levine Cancer, Charlotte, NC, USA., Zeng H; Department of Biostatistics and Data Science, Atrium Health Levine Cancer, Charlotte, NC, USA., Benfield M; Department of Pharmacy, Atrium Health Levine Cancer, Charlotte, NC, USA., Davis JM; Department of Pharmacy, Atrium Health Levine Cancer, Charlotte, NC, USA. |
| Source: | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2026 Jun; Vol. 32 (4), pp. 747-753. Date of Electronic Publication: 2026 Feb 26. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-092X |
|---|---|
| DOI: | 10.1177/10781552261422159 |
